Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 13.09-1,872.7511.327.3013.65

What is the latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of BALAXI PHARMACEUTICALS is 13.09 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202513.09
Mar2024-1,872.75
Mar202311.32
Mar20227.30
Mar202113.65

How is Price to Cash Earnings (PCE) of BALAXI PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 13.09
Positive
Mar2024 -1872.75
Negative
Mar2023 11.32
55.07
Mar2022 7.3
-46.52
Mar2021 13.65 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹108.9 Cr -2.9% -19.1% -64.8% Stock Analytics
ADANI ENTERPRISES ₹279,840.0 Cr -1.1% 7.2% 7% Stock Analytics
REDINGTON ₹21,948.3 Cr 14.3% 3.3% -2.7% Stock Analytics
HONASA CONSUMER ₹9,862.0 Cr -1.3% 9.7% 37.3% Stock Analytics
MMTC ₹9,292.5 Cr 0.7% -4.8% 9.1% Stock Analytics
LLOYDS ENTERPRISES ₹7,808.3 Cr -4.1% -12.1% 16.6% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-2.9%

-19.1%

-64.8%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses